Brewin Dolphin LTD Dynavax Technologies Corp Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2023
SELL
$9.16 - $19.83 $22,900 - $49,574
-2,500 Reduced 25.28%
7,390 $142 Million
Q1 2018

Nov 09, 2023
BUY
$14.65 - $19.9 $5,713 - $7,760
390 Added 4.11%
9,890 $196 Million
Q4 2017

Nov 09, 2023
BUY
$17.3 - $24.08 $17,300 - $24,080
1,000 Added 11.76%
9,500 $178 Million
Q3 2017

Nov 09, 2023
BUY
$15.2 - $21.5 $129,200 - $182,750
8,500
8,500 $183 Million

Others Institutions Holding DVAX

# of Institutions
288
Shares Held
131M
Call Options Held
507K
Put Options Held
374K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email